Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

NCT00469209 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Trisenox (Arsenic Trioxide)
DRUG: Velcade (Bortezomib)
DRUG: Melphalan
DRUG: Vitamin C (Ascorbic Acid)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]